Federal Circuit Upholds Pfizer Patent, Blocks Generic Xalatan
By Marius Meland · August 14, 2005, 12:00 AM EDT
Pfizer Inc.'s glaucoma drug Xalatan is off limits to generics manufacturer Par Pharmaceutical Inc., following a decision in Pfizer's favor by the U.S. Court of Appeals for the Federal Circuit....
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login